Filing Details

Accession Number:
0001562180-23-005506
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-27 08:07:48
Reporting Period:
2023-06-26
Accepted Time:
2023-06-27 08:07:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1822791 Clene Inc. CLNN Pharmaceutical Preparations (2834) 852828339
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1835330 Dee Robert Etherington 6550 South Millrock Drive
Suite G50
Salt Lake City UT 84121
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-06-26 25,000 $0.81 25,000 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 56,593 Direct
Common Stock 12,717 Indirect By LLC
Footnotes
  1. Etherington Revocable Trust purchased 25,000 shares of common stock of Clene Inc. in multiple transactions on June 26, 2023 at prices ranging from $0.80 to $0.82, inclusive, for a weighted average price of $0.81 per share.
  2. The securities are owned by the Etherington Revocable Trust. Mr. Etherington is the co-trustee of the Etherington Revocable Trust. The shares owned by the Etherington Revocable Trust may be deemed to be beneficially owned by Mr. Etherington.
  3. The securities are owned by RDE RX Ventures LLC. Mr. Etherington is the manager of RDE RX Ventures LLC. The shares owned by RDE RX Ventures LLC may also be deemed to be beneficially owned by Mr. Etherington.